Clinical Trial Update: Impact of Dialysis Modality on Hepcidin and Iron Metabolism

View source ↗

Summary

A completed clinical trial evaluating how dialysis modality influences hepcidin and iron metabolism in patients with end-stage renal disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Snippet

Sponsor: Kyungpook National University Hospital | Conditions: End-stage Renal Disease | Status: COMPLETED